載入...

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

Dasatinib is associated with increased risk of bleeding among patients with chronic myeloid leukemia, even in the absence of thrombocytopenia, suggesting the presence of a hemostatic defect. We tested platelet aggregation in 91 patients with chronic myeloid leukemia in chronic phase either off-thera...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Quintás-Cardama, Alfonso, Han, Xin, Kantarjian, Hagop, Cortes, Jorge
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2009
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952950/
https://ncbi.nlm.nih.gov/pubmed/19414863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-180604
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!